Paras Healthcare IPO Review
Paras Healthcare IPO is yet to receive analyst coverage — analyst reports and verdicts will be updated here as and when they are published. Subscription opens on 21 Oct 2026 and closes on 23 Oct 2026. The issue size is ₹1,450 crore, a mix of fresh issue and offer for sale. In the meantime, you can track the live GMP and subscription status for early market signals.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Detailed review
Download our Android App to check other reviews.
Latest IPO reviews
How analysts rated the most recent mainboard issues — and, where they have listed, how the call played out.
Frequently asked
Should I apply for Paras Healthcare IPO?
Analyst coverage for Paras Healthcare IPO has not been published yet. Verdicts will be added here as analyst reports come in. IPO Guru does not make buy or sell recommendations. Read the individual analyst reports and consult a SEBI-registered advisor before investing.
What does the score of N/A mean for Paras Healthcare IPO?
Analyst scoring is not yet available for Paras Healthcare IPO. The score will be updated once analyst reports start coming in.
What are the listing gain expectations for Paras Healthcare IPO?
The grey market premium (GMP) for Paras Healthcare IPO is currently ₹83 (%), suggesting the street is pricing a listing above the issue price. GMP is an unofficial, unregulated indicator and can shift sharply in the 24–48 hours before listing. Live GMP →
What is the price band and lot size of Paras Healthcare IPO?
The subscription window is open from 21 Oct 2026 to 23 Oct 2026.
Explore Paras Healthcare IPO further
Analyst views are one input. Read them alongside the demand, the grey market and the filings before you decide.
Price band, lot size, financials, objects of the issue and promoters.
Before the book opens, see how the grey market is pricing it.
Category-wise demand from QIB, NII and retail investors, updated through the day.
Check with your PAN whether shares were credited to your demat account.
A verdict is an opinion, not a guarantee.
IPO Guru collects analyst views, GMP, subscription and allotment for every Mainboard and SME issue. Weigh them together — and against the offer document — before you apply.
Disclaimer: Grey Market Premium (GMP) is for information purposes and is not a guarantee of listing price. Always consult your financial advisor before investing.
